Cargando…
Challenges in the Clinical Application of the American Society of Clinical Oncology Value Framework: A Medicare Cost-Benefit Analysis in Chronic Lymphocytic Leukemia
The ASCO Value Framework calculates the value of cancer therapies. Given costly novel therapeutics for chronic lymphocytic leukemia, we used the framework to compare net health benefit (NHB) and cost within Medicare of all regimens listed in the National Comprehensive Cancer Network (NCCN) guideline...
Autores principales: | Seymour, Erlene K., Schiffer, Charles A., de Souza, Jonas A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797243/ https://www.ncbi.nlm.nih.gov/pubmed/29144866 http://dx.doi.org/10.1200/JOP.2017.024778 |
Ejemplares similares
-
Rapid transitions in the standard of care for chronic lymphocytic leukemia (CLL)
por: Seymour, Erlene K.
Publicado: (2019) -
Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update
por: Recht, Abram, et al.
Publicado: (2016) -
The Cost of Cancer-Related Physician Services to Medicare
por: Maroongroge, Sean, et al.
Publicado: (2015) -
American Cancer Society textbook of clinical oncology /
Publicado: (1991) -
American Society of Clinical Oncology Reports on Clinical Cancer Advances
por: Viale, Pamela Hallquist
Publicado: (2019)